{"id":"https://openalex.org/W4404903860","doi":"https://doi.org/10.1038/s41573-024-01102-3","title":"Antiviral target compound profile for pandemic preparedness","display_name":"Antiviral target compound profile for pandemic preparedness","publication_year":2024,"publication_date":"2024-12-02","ids":{"openalex":"https://openalex.org/W4404903860","doi":"https://doi.org/10.1038/s41573-024-01102-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/39622985"},"language":"en","primary_location":{"id":"doi:10.1038/s41573-024-01102-3","doi":"https://doi.org/10.1038/s41573-024-01102-3","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41573-024-01102-3","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018060515","display_name":"James F. Demarest","orcid":"https://orcid.org/0000-0003-0303-9261","observed_orcids":["https://orcid.org/0000-0003-0303-9261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James F. Demarest","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034671396","display_name":"Ruxandra Draghia","orcid":"https://orcid.org/0000-0001-6372-4039","observed_orcids":["https://orcid.org/0000-0001-6372-4039"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruxandra Draghia-Akli","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030919816","display_name":"Tom\u00e1\u0161 Cihl\u00e1\u0159","orcid":"https://orcid.org/0000-0001-6840-0885","observed_orcids":["https://orcid.org/0000-0001-6840-0885"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tomas Cihlar","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA","INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]},{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056283289","display_name":"Kenneth A. Bradley","orcid":"https://orcid.org/0000-0002-4757-5122","observed_orcids":["https://orcid.org/0000-0002-4757-5122"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Kenneth Bradley","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA","Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]},{"raw_affiliation_string":"Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072970065","display_name":"John A. T. Young","orcid":"https://orcid.org/0000-0003-1824-2561","observed_orcids":["https://orcid.org/0000-0003-1824-2561"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"John A. T. Young","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA","Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]},{"raw_affiliation_string":"Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107701501","display_name":"Richa Chandra","orcid":"https://orcid.org/0000-0002-7754-5901","observed_orcids":["https://orcid.org/0000-0002-7754-5901"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richa Chandra","raw_affiliation_strings":["Novartis Pharmaceuticals, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002715359","display_name":"Sujata Vaidyanathan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sujata Vaidyanathan","raw_affiliation_strings":["Novartis Pharmaceuticals, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082045002","display_name":"Margaret Y. Chu\u2010Moyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret Chu-Moyer","raw_affiliation_strings":["Amgen, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher L. Lynch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher L. Lynch","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047822288","display_name":"Andrew L. Campbell","orcid":"https://orcid.org/0000-0001-9810-1173","observed_orcids":["https://orcid.org/0000-0001-9810-1173"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Campbell","raw_affiliation_strings":["AbbVie, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086304347","display_name":"Kumar Singh Saikatendu","orcid":"https://orcid.org/0000-0001-6734-237X","observed_orcids":["https://orcid.org/0000-0001-6734-237X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kumar Singh Saikatendu","raw_affiliation_strings":["Takeda, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073248934","display_name":"John P. Bilello","orcid":"https://orcid.org/0000-0003-4327-1727","observed_orcids":["https://orcid.org/0000-0003-4327-1727"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P. Bilello","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070084046","display_name":"Yoshihiko Murata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshihiko Murata","raw_affiliation_strings":["Gilead Sciences, Foster City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA, USA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065248443","display_name":"Marnix Van Loock","orcid":"https://orcid.org/0000-0003-4151-4588","observed_orcids":["https://orcid.org/0000-0003-4151-4588"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marnix van Loock","raw_affiliation_strings":["Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103128939","display_name":"Aeron C. Hurt","orcid":"https://orcid.org/0000-0001-9731-3481","observed_orcids":["https://orcid.org/0000-0001-9731-3481"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Aeron C. Hurt","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047582862","display_name":"Timothy L. Tellinghuisen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Timothy Tellinghuisen","raw_affiliation_strings":["Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche pharmaceutical Research and Early Development (pRED), Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lee Ruggiero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lee Ruggiero","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004097886","display_name":"Richard L. Mackman","orcid":"https://orcid.org/0000-0001-8861-7205","observed_orcids":["https://orcid.org/0000-0001-8861-7205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Mackman","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047454253","display_name":"Nina Hill","orcid":"https://orcid.org/0000-0001-6772-0991","observed_orcids":["https://orcid.org/0000-0001-6772-0991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nina M. Hill","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0001-6772-0991","affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058275680","display_name":"John C. Pottage","orcid":"https://orcid.org/0000-0002-5273-1783","observed_orcids":["https://orcid.org/0000-0002-5273-1783"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John C. Pottage","raw_affiliation_strings":["INTREPID Alliance, Cambridge, MA, USA. john.pottagemd@gmail.com","INTREPID Alliance, Cambridge, MA, USA"],"raw_orcid":"https://orcid.org/0000-0002-5273-1783","affiliations":[{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA. john.pottagemd@gmail.com","institution_ids":[]},{"raw_affiliation_string":"INTREPID Alliance, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"on behalf of the INTREPID Alliance","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"on behalf of the INTREPID Alliance","raw_affiliation_strings":["Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"last","author":{"id":null,"display_name":"Marnix van Loock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marnix van Loock","raw_affiliation_strings":["Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Pharmaceutica NV, a Johnson & Johnson company, Beerse, Belgium","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5058275680"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2237,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.88611856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"24","issue":"2","first_page":"151","last_page":"152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.260699987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.260699987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.23319999873638153,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.12290000170469284,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.796999990940094},{"id":"https://openalex.org/keywords/target-product-profile","display_name":"target product profile","score":0.9169999957084656},{"id":"https://openalex.org/keywords/pandemic-preparedness","display_name":"pandemic preparedness","score":0.7919999957084656},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.8360000252723694},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8889999985694885},{"id":"https://openalex.org/keywords/regulatory-guidance","display_name":"regulatory guidelines","score":0.421999990940094},{"id":"https://openalex.org/keywords/safety-pharmacology","display_name":"safety pharmacology","score":0.7749999761581421},{"id":"https://openalex.org/keywords/proarrhythmic-potential","display_name":"proarrhythmic potential","score":0.8009999990463257},{"id":"https://openalex.org/keywords/neglected-diseases","display_name":"neglected diseases","score":0.4650000035762787},{"id":"https://openalex.org/keywords/regulatory-communication","display_name":"regulatory communication","score":0.5350000262260437},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.7231065034866333},{"id":"https://openalex.org/C2777042776","wikidata":"https://www.wikidata.org/wiki/Q4583103","display_name":"Preparedness","level":2,"score":0.722611665725708},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.6437217593193054},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5614921450614929},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5601328015327454},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.5256337523460388},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39659637212753296},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.11419475078582764},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.10193943977355957},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08715254068374634},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08712798357009888},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.07766318321228027},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1038/s41573-024-01102-3","doi":"https://doi.org/10.1038/s41573-024-01102-3","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s41573-024-01102-3","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},{"id":"pmid:39622985","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39622985","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Drug discovery","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W2198907191","https://openalex.org/W2588719504","https://openalex.org/W4376277283"],"related_works":["https://openalex.org/W2154062035","https://openalex.org/W4242902198","https://openalex.org/W4376277283","https://openalex.org/W6912971039","https://openalex.org/W4399910261","https://openalex.org/W7203546324","https://openalex.org/W2750438295","https://openalex.org/W7098473603","https://openalex.org/W3099394734","https://openalex.org/W7139953426"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2024-12-02T00:00:00"}